Predicting Periodontal Treatment Success Using Machine Learning in Periodontitis Patients

July 3, 2026 updated by: Nezahat Arzu Kayar, Akdeniz University

Development of a Machine Learning-Assisted Model for Predicting Post-Periodontal Treatment Success and Individual Risk Analysis: A Retrospective Cohort Study

This retrospective observational study aims to develop treatment-specific machine learning models for predicting tooth-level periodontal treatment outcomes among teeth treated with non-surgical periodontal treatment, conventional flap surgery, or regenerative periodontal surgery. The study uses a multidimensional dataset including baseline clinical periodontal parameters, radiographic findings, documented treatment modalities, and patient-level demographic and clinical characteristics.

The analytical unit of the study is the tooth. Only periodontally involved teeth with complete baseline and follow-up clinical records, radiographic assessment, clearly documented treatment modality, and measurable periodontal outcomes are included in the predictive analyses. Full-mouth periodontal information is used for patient-level disease characterization, including periodontal staging and grading according to the 2017 AAP/EFP classification.

Because treatment allocation was not randomized, the models are intended to support treatment-specific outcome prediction and clinical interpretability rather than to establish causal superiority between treatment modalities.

Study Overview

Detailed Description

Periodontitis is a chronic, multifactorial inflammatory disease characterized by progressive destruction of the supporting periodontal tissues. Although contemporary periodontal classification systems provide a structured framework for diagnosis, staging, and grading, prediction of treatment response remains challenging because outcomes may vary according to patient-level characteristics, local tooth-level conditions, defect morphology, baseline periodontal status, and treatment modality.

Periodontal treatment may include non-surgical periodontal therapy, conventional flap surgery, or regenerative periodontal surgery, depending on clinical indication and local periodontal findings. In routine clinical practice, treatment decisions are individualized and based on clinical examination, radiographic assessment, defect characteristics, and clinician judgment. However, the ability to predict treatment response before or during treatment planning remains limited.

This retrospective observational study uses archived clinical and radiographic records to develop treatment-specific machine learning models for predicting periodontal treatment outcomes at the tooth level. The study focuses on periodontally involved teeth with documented treatment modality and measurable follow-up outcomes. Baseline clinical periodontal parameters, radiographic findings, treatment modality, and relevant patient-level characteristics are used to support outcome prediction and model interpretability.

The purpose of the study is not to establish causal superiority between treatment modalities, but to evaluate whether machine learning models can provide clinically interpretable, treatment-specific predictions of periodontal treatment response. Explainable artificial intelligence methods are used to identify variables contributing to model predictions and to support future development of personalized periodontal treatment planning.

Study Type

Observational

Enrollment (Actual)

126

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • konyaaltı
      • Antalya, konyaaltı, Turkey (Türkiye), 07070
        • Akdeniz University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population consists of patients diagnosed with periodontitis who attended the Department of Periodontology, Faculty of Dentistry, Akdeniz University, between 2021 and 2025. Patients were identified retrospectively from archived clinical and radiographic records. Eligible patients had completed active periodontal therapy and had complete baseline and follow-up records. The analytical unit was the tooth; only periodontally involved teeth with documented treatment modality and measurable treatment outcomes were included in the predictive analyses.

Description

Inclusion Criteria:

  1. Patients with a confirmed diagnosis of periodontitis according to the 2017 AAP/EFP classification, supported by complete clinical and radiographic records.
  2. Availability of baseline clinical periodontal examination and radiographic records before periodontal treatment.
  3. Completion of active periodontal therapy, including non-surgical periodontal treatment and/or surgical periodontal treatment when clinically indicated.
  4. Availability of at least one post-treatment follow-up visit after completion of active periodontal therapy.
  5. Presence of at least one periodontally involved tooth meeting tooth-level eligibility criteria.
  6. Availability of detailed tooth-level documentation, including baseline periodontal measurements, radiographic assessment, documented treatment modality, and corresponding post-treatment outcome records.
  7. Teeth were eligible for tooth-level analysis if they received one of the predefined periodontal treatment modalities: non-surgical periodontal treatment, conventional flap surgery, or regenerative periodontal surgery.
  8. Patients with a previous history of cancer were eligible if chemotherapy or radiotherapy had been completed and medical clearance for periodontal treatment had been obtained.

Exclusion Criteria:

  1. Incomplete demographic, clinical, radiographic, treatment, or follow-up records.
  2. Unclear or undocumented periodontal treatment modality.
  3. Systemic conditions contraindicating periodontal treatment or substantially affecting periodontal treatment outcomes.
  4. Pregnancy or breastfeeding at the time of periodontal treatment.
  5. Ongoing chemotherapy or radiotherapy.
  6. Current or previous bisphosphonate therapy affecting periodontal or surgical treatment eligibility.
  7. Presence of an immunocompromised condition.
  8. Acute systemic illness or active infection at the time of periodontal evaluation or treatment.
  9. Teeth with missing baseline or follow-up periodontal measurements, missing radiographic assessment, unclear treatment allocation, or insufficient documentation for outcome assessment were excluded from the tooth-level analysis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Phase-1 Periodontal Therapy
Patients who received non-surgical periodontal treatment consisting of oral hygiene instructions, scaling, and root planing (SRP).
Non-surgical periodontal treatment consisting of scaling and root planing (SRP) under local anesthesia, along with oral hygiene instructions
Conventional Flap Surgery
Patients who underwent traditional periodontal flap surgery (access flap) following unsuccessful non-surgical therapy to reduce pocket depth.
Periodontal access flap surgery performed for subgingival debridement and pocket depth reduction in cases unresponsive to Phase-1 therapy.
Regenerative Flap Surgery
Patients who underwent periodontal surgery involving regenerative materials (bone grafts, membranes, or enamel matrix derivatives) for the treatment of intrabony defects.
Surgical intervention utilizing regenerative materials such as bone grafts or barrier membranes for the treatment of periodontal intrabony defects.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tooth-level Clinical Success of Periodontal Treatment
Time Frame: Baseline and final post-treatment follow-up after completion of active periodontal therapy; 12 to 48 months.
Binary tooth-level classification of periodontal treatment outcome as clinical success or clinical failure after completion of active periodontal therapy. The outcome was assessed for each eligible periodontally treated tooth by comparing baseline (T0) and final follow-up (T1) clinical records. Tooth-level clinical treatment success was defined as the simultaneous presence of residual probing pocket depth (PPD) ≤4 mm and absence of bleeding on probing (BOP) at the T1 (final follow-up) examination. As a secondary, machine-learning-oriented outcome, treatment response was categorized using a ≥50% relative reduction in PPD between baseline (T0) and final follow-up (T1), with cases meeting this threshold labeled 'high responders. This primary clinical outcome was analyzed separately from the machine-learning classification outcome based on the ≥50% probing pocket depth reduction threshold.
Baseline and final post-treatment follow-up after completion of active periodontal therapy; 12 to 48 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 2, 2025

Primary Completion (Actual)

January 31, 2026

Study Completion (Actual)

January 31, 2026

Study Registration Dates

First Submitted

March 17, 2026

First Submitted That Met QC Criteria

March 17, 2026

First Posted (Actual)

March 20, 2026

Study Record Updates

Last Update Posted (Actual)

July 7, 2026

Last Update Submitted That Met QC Criteria

July 3, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • TBAEK-608
  • TDH-2025-6980 (Other Identifier: BAP)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontitis

Clinical Trials on Phase-1 Periodontal Therapy

Subscribe